ArticleOncoimmunology2020

T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.